{"title":"Effect of probiotics on prevention of ventilator-associated pneumonia and intestinal function in critically ill patients","authors":"Ying Xu, Rui-Xiang Chen, Jun Jin","doi":"10.3760/CMA.J.CN131368-20190906-01252","DOIUrl":null,"url":null,"abstract":"Objective \nTo observe the effect of probiotics on prevention of ventilator-associated pneumonia (VAP) and intestinal function in critically ill patients. \n \n \nMethods \nIn this prospective, randomized, controlled study, 155 patients who met the conditions for enrollment were randomly divided into control group and test group.The same treatment was given to all patients, in addition, the patients in test group were given probiotics (Bifidobacterium, Lactobacillus mixture) for three weeks.The incidence of VAP, changes in gut microbiota and incidence of gastrointestinal symptoms were compared between the two groups. \n \n \nResults \n120 patients finished the study, including 58 cases in the control group and 62 cases in the test group.The incidence of VAP in the test group was lower than that in the control group (38.7% vs 62.1%, χ2=6.541, P<0.05). The total detection rate of microbial colonization in the oropharynx and stomach of the test group was significantly lower than that of the control group (51.6% vs 89.7%, χ2=20.052, P<0.05). The incidences of increased intra-abdominal pressure, diarrhea, and weakened or disappeared bowel sounds were significantly reduced in the test group (χ2=8.439, 10.849, 13.327, all P<0.05). The proportion of lactobacillus in the intestinal tract of the test group was significantly increased.The time of mechanical ventilation and length of stay in intensive care unit in the test group were also significantly shortened compared with the control group (t=8.051, 6.538, all P<0.05). \n \n \nConclusions \nProbiotics preparation can significantly increase the proportion of lactobacillus in the intestinal tract, reduce the incidence of VAP in critically ill patients, reduce the incidence of gastrointestinal symptoms, reduce the time of mechanical ventilation and the length of stay in intensive care unit, then have the value of clinical promotion. \n \n \nKey words: \nProbiotics; Pneumonia, ventilator-associated; Gut microbiota; Lactobacillus","PeriodicalId":10004,"journal":{"name":"Chinese Journal of Asthma","volume":"1 1","pages":"437-441"},"PeriodicalIF":0.0000,"publicationDate":"2020-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese Journal of Asthma","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3760/CMA.J.CN131368-20190906-01252","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
To observe the effect of probiotics on prevention of ventilator-associated pneumonia (VAP) and intestinal function in critically ill patients.
Methods
In this prospective, randomized, controlled study, 155 patients who met the conditions for enrollment were randomly divided into control group and test group.The same treatment was given to all patients, in addition, the patients in test group were given probiotics (Bifidobacterium, Lactobacillus mixture) for three weeks.The incidence of VAP, changes in gut microbiota and incidence of gastrointestinal symptoms were compared between the two groups.
Results
120 patients finished the study, including 58 cases in the control group and 62 cases in the test group.The incidence of VAP in the test group was lower than that in the control group (38.7% vs 62.1%, χ2=6.541, P<0.05). The total detection rate of microbial colonization in the oropharynx and stomach of the test group was significantly lower than that of the control group (51.6% vs 89.7%, χ2=20.052, P<0.05). The incidences of increased intra-abdominal pressure, diarrhea, and weakened or disappeared bowel sounds were significantly reduced in the test group (χ2=8.439, 10.849, 13.327, all P<0.05). The proportion of lactobacillus in the intestinal tract of the test group was significantly increased.The time of mechanical ventilation and length of stay in intensive care unit in the test group were also significantly shortened compared with the control group (t=8.051, 6.538, all P<0.05).
Conclusions
Probiotics preparation can significantly increase the proportion of lactobacillus in the intestinal tract, reduce the incidence of VAP in critically ill patients, reduce the incidence of gastrointestinal symptoms, reduce the time of mechanical ventilation and the length of stay in intensive care unit, then have the value of clinical promotion.
Key words:
Probiotics; Pneumonia, ventilator-associated; Gut microbiota; Lactobacillus
目的观察益生菌对危重患者呼吸机相关性肺炎(VAP)及肠道功能的预防作用。方法采用前瞻性、随机、对照研究,将155例符合入组条件的患者随机分为对照组和试验组。所有患者均给予相同治疗,试验组患者给予益生菌(双歧杆菌、乳酸菌混合物)治疗3周。比较两组患者VAP发生率、肠道菌群变化及胃肠道症状发生率。结果120例患者完成研究,其中对照组58例,试验组62例。试验组VAP发生率低于对照组(38.7% vs 62.1%, χ2=6.541, P<0.05)。试验组口咽、胃微生物定植总检出率显著低于对照组(51.6% vs 89.7%, χ2=20.052, P<0.05)。试验组患者腹内压升高、腹泻、肠音减弱或消失的发生率均显著降低(χ2=8.439、10.849、13.327,均P<0.05)。试验组肠道乳酸菌比例显著升高。试验组机械通气时间、重症监护病房住院时间均显著缩短(t=8.051、6.538,P均<0.05)。结论益生菌制剂可显著提高肠道乳酸菌比例,降低危重症患者VAP发生率,降低胃肠道症状发生率,减少机械通气时间和重症监护病房住院时间,具有临床推广价值。关键词:益生菌;与机械通气相关;肺炎,肠道微生物群;乳酸菌